Atlas Trials

Bioequivalence Fasting Study in Patients

Clinical trial NCT02072954 · COMPLETED

Trial details

NCT number
NCT02072954
Sponsor
Amneal Pharmaceuticals, LLC
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2013-11-01
Primary completion
2014-02-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.